Minimally Invasive Imaging Market Size, Share, Opportunities, And Trends By System (Organ Preservation Solutions, Transplant Diagnostics, Tissue Products, Others), By End-Users (Hospitals, Diagnostic Centers, Others), And By Geography - Forecasts From 2025 To 2030

Minimally Invasive Imaging Market Size:

The global minimally invasive imaging market is expected to grow from USD 24.484 billion in 2025 to USD 31.474 billion in 2030, at a CAGR of 5.15%.

The global minimally invasive imaging market is thriving on the back of technological advancements in the field of medical devices, which are resulting in greater efficiency, faster disease detection times, improved diagnostic processes, and greater productivity in patient monitoring, combined with factors such as strict autoclaving regulations, the growing demand for minimally invasive medical imaging systems, and increasing cases of chronic disorders. Furthermore, rising investments in the healthcare industry by both public and private entities, as well as an increasing trend to take early action for disease prevention as a step toward preventive healthcare, will propel the market.

The market is boosted by the growing prevalence of chronic diseases and the increasing geriatric population. With age, the chance of getting illnesses rises correspondingly. Nearly 80% of the elderly in the US have at least one chronic illness, according to the Centers for Disease Control and Prevention. Furthermore, the American Medical Association predicts that by 2030, at least 60% of people aged 65 and up will have more than one chronic illness. According to the National Brain Tumor Society, 700,000 persons in the United States will be living with a brain tumour in 2020, with an additional 87,000 projected to be diagnosed. The prevalence of age-related disorders such as Alzheimer's disease, arthritis, Parkinson's disease, dementia, cancer, as well as cardiovascular diseases is predicted to rise as the worldwide geriatric population grows. The demand for new treatment choices, better healthcare facilities, and drugs will rise as the population ages.

The high cost of minimally invasive imaging systems, scarcity of skilled technicians, and strict government policies for complicated testing regimes are major factors limiting the market for minimally invasive imaging systems. Furthermore, due to certain technical restrictions associated with solitary imaging modalities, researchers are hesitant to purchase them, limiting their market expansion. For instance, CT has poor soft-tissue contrast; therefore, it provides less information on functional qualities and exposes doctors and patients to radiation.

Minimally Invasive Imaging Market Segmentation Analysis:

• By system

The global minimally invasive imaging market can be segmented into ultrasound, CT, X-ray, MRI, and others. The X-ray sector is expected to dominate the global minimally invasive imaging industry owing to the increasing use of direct radiography. The ultrasound segment is also expected to grow in the projected period.

• By End-Users

The global minimally invasive imaging market can be segmented into diagnostic centres, hospitals, and others, including specialty clinics and research centres. The hospital segment is expected to account for the most significant proportion. Owing to the increased demand for medical imaging modalities such as MRI systems and CT scanners in hospital settings for precise diagnosis during procedures will help propel the market forward. Furthermore, hospitals are well-equipped with medical imaging technology and competent healthcare experts to correctly treat and diagnose the bodily parts of patients.

Minimally Invasive Imaging Market Geographical Outlook:

The global minimally invasive imaging market can be segmented into the Asia Pacific, North America, the Middle East and Africa, South America, and Europe. Over the projected period, North America is expected to have a significant market share due to improved healthcare infrastructure and higher R&D investment in the healthcare industry, as well as the U.S. government's rising measures to update the healthcare system. The Asia Pacific region is expected to grow rapidly due to developing medical tourism in Asia Pacific countries such as India and the growing geriatric population in the region.

Minimally Invasive Imaging Market Scope:

Minimally Invasive Imaging Market Segmentation

• By Imaging Type
  • Ultrasound
  • Magnetic Resonance Imaging (MRI)
  • X-Ray
  • Computed Tomography (CT)
  • Other
• By Application
  • Cardiology
  • Neurology
  • Oncology
  • Orthopedics
  • Others
• By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • iddle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Taiwan
    • Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MINIMALLY INVASIVE IMAGING MARKET BY IMAGING TYPE

5.1. Introduction

5.2. Ultrasound

5.3. Magnetic Resonance Imaging (MRI)

5.4. X-Ray

5.5. Computed Tomography (CT)

5.6. Others

6. GLOBAL MINIMALLY INVASIVE IMAGING MARKET BY APPLICATION

6.1. Introduction

6.2. Cardiology

6.3. Neurology

6.4. Oncology

6.5. Orthopedics

6.6. Others

7. GLOBAL MINIMALLY INVASIVE IMAGING MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Ambulatory Surgical Centers

7.4. Diagnostic Imaging Centers

7.5. Others

8. GLOBAL MINIMALLY INVASIVE IMAGING MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Hitachi High-Tech Corporation

10.2. GE Healthcare

10.3. Boston Scientific Corporation

10.4. Medtronic Plc

10.5. Koninklijke Philips N.V.

10.6. Canon Inc.

10.7. Carestream Health

10.8. Trivitron Healthcare

10.9. FUJIFILM Corporation.

10.10. Siemens Healthineers

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

Hitachi High-Tech Corporation

GE Healthcare

Boston Scientific Corporation

Medtronic Plc

Koninklijke Philips N.V.

Canon Inc.

Carestream Health

Trivitron Healthcare

FUJIFILM Corporation.

Siemens Healthineers

Sorry, the research methodology content could not be loaded.